| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/29/2008 | US7405305 Pyrrole-2, 5dione derivatives and their used as GSK-3 inhibitors |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405215 e.g. [3-(3-benzyl-4-oxo-3,4-dihydro-phthalazin-1-yl)-indol-1-yl]-acetic acid; inhibit binding of endogenous ligands, including prostaglandin PGD2 and its metabolites and certain thromboxane metabolites (such as 11-dehydro-TXB2), to CRTH2; antiallergent; asthma, bronchitis, rhinitis, cough, psoriasis |
| 07/29/2008 | US7405209 Protease inhibitors |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2214086C Pyrazole derivatives and processes for the preparation thereof |
| 07/24/2008 | WO2008089005A2 Renin inhibitors |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087529A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | WO2008087514A2 Hdac inhibitors |
| 07/24/2008 | WO2008087401A1 Sulfate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087399A1 Mesylate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087397A1 Tosylate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087278A2 5-alkyloxy-indolin-2-one derivatives, preparation thereof and application thereof in therapy as selective ligands of v2 vasopressin receptors |
| 07/24/2008 | WO2008087178A1 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 07/24/2008 | WO2008086733A1 New pharmaceutical composition |
| 07/24/2008 | WO2008065068A3 Substituted dihydroimidazoles and their use in the treatment of tumors |
| 07/24/2008 | WO2008060190A3 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 07/24/2008 | WO2008051406A3 Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 07/24/2008 | WO2008045686A3 Enantiomerically enriched iminopyrrolidone azirdine compositions |
| 07/24/2008 | WO2008011392A8 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 07/24/2008 | WO2007120718A3 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 07/24/2008 | WO2007080401A8 Triazoloanilinopyrimidine derivatives for use as antiviral agents |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080177064 Dipeptidyl peptidase inhibitors |
| 07/24/2008 | US20080176938 Modulation of pathogenicity |
| 07/24/2008 | US20080176922 Uses of 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssris |
| 07/24/2008 | US20080176917 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane |
| 07/24/2008 | US20080176904 Such as 1-(2,2-dimethylpropyl)-4-propyl-5-{4-[4-(1H-tetrazol-5-yl)phenoxy]butoxy}-1H-indole; neurological and psychiatric disorders |
| 07/24/2008 | US20080176896 Modulators of cellular adhesion |
| 07/24/2008 | US20080176880 Activity against strains having acquired resistance nonnucleoside reverse transcriptase inhibitors; human alpha1 acid glycoprotein nonbinding; such as 4-[[(5-bromo-4,6-dichloro)-2-pyrimidinyl]amino]-benzonitrile |
| 07/24/2008 | US20080176876 Substituted 2-Alkyl Quinazolinone Derivatives as Parp Inhibitors |
| 07/24/2008 | US20080176865 Substituted arylpyrazoles |
| 07/24/2008 | US20080176864 [4-(3-Methoxy-phenyl)-4-oxo-butyl]-carbamic acid tert-butyl ester; Age related functional decline, osteoporosis, osteopenia, bone fractures, male and female sexual dysfunction, erectile dysfunction, depression, prostate cancer, decreased cognitive ability, or lethargy |
| 07/24/2008 | US20080176863 Capped pyrazinoylguanidine sodium channel blockers |
| 07/24/2008 | US20080176862 New Compounds 617 |
| 07/24/2008 | US20080176854 Nitro-Substituted Phenyl-Piperazine Compounds, Their Preparation and Use in Medicaments |
| 07/24/2008 | US20080176853 Triazine derivatives and their therapeutical applications |
| 07/24/2008 | US20080176849 e.g. N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]-amino]methyl]phenyl]-2E-2-propenamide; histone deacetylase inhibitor; anticarcinogenic, antitumor, antiproliferative agents; improved stability |
| 07/24/2008 | US20080176848 e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders |
| 07/24/2008 | US20080176847 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 07/24/2008 | US20080176842 N1-[1-[N-(2-methylpropyl)-N-(phenylsulfonyl)amino]-2R-hydroxy-3S-(phenylmethyl)prop-3-yl]-3-(1-morpholinosulfonyl)-2R-methylpropionamide; viricide; human T-cell leukemia/limphoma virus |
| 07/24/2008 | US20080176840 e.g. 4-(4-(6-(N-(2-methoxyethyl)-N-methylamino)pyridin-3-yl)-5-hydroxy-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol; Heat Shock Protein 90 (HSP90) modulator; antiproliferative, anticarcinogenic, antiinflammatory agent; angiogenesis inhibition, infections |
| 07/24/2008 | US20080176831 e.g. 1-[4-chloro-6-(2,2,2-trifluoro-1-methylethylamino)-5-(2,4,6-trifluorophenyl)pyrimidin-2-yl]-pyrrolidin-2-one; controlling phytopathogenic harmful fungi, such as Ascomycetes, Deuteromycetes, Oomycetes and Basidiomycetes; materials, plants, soil, seeds; |
| 07/24/2008 | US20080175789 Prostate specific membrane antigen (PSMA); for diagnosis, detection and treatment of cancer; gene overexpression; kits |
| 07/24/2008 | US20080174237 Carbazole-based compound and organic light-emitting device including organic layer including the carbazole-based compound |
| 07/24/2008 | CA2675676A1 Nicotinic acetylcholine receptor modulators |
| 07/24/2008 | CA2674865A1 Indole derivative having i.kappa.b kinase .beta. inhibitory activity |
| 07/23/2008 | EP1947100A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 07/23/2008 | EP1947090A1 Method for preparing N-piperidino-1,5-diphenylpyrazole-3-carboxamide and derivatives |
| 07/23/2008 | EP1945631A1 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer |
| 07/23/2008 | EP1945630A2 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 07/23/2008 | EP1945629A1 Process for the preparation of candesartan cilexetil |
| 07/23/2008 | EP1945628A1 New pyrimidine derivatives and their use in therapy as well as the use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease |
| 07/23/2008 | EP1945626A1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists |
| 07/23/2008 | EP1945616A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 07/23/2008 | EP1945612A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 07/23/2008 | EP1945609A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 07/23/2008 | EP1945219A2 Compound |
| 07/23/2008 | EP1945206A1 Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
| 07/23/2008 | EP1671949B1 Substituted Pyridinylamines |
| 07/23/2008 | EP1625119B1 Substituted-1-phthalazinamines as vr-1 antagonists |
| 07/23/2008 | EP1382603B1 Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
| 07/23/2008 | EP1315715B1 Quinazoline derivatives as kinase inhibitors |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1044199B1 Heterocyclic topoisomerase poisons |
| 07/23/2008 | CN101228156A Fungicidal carboxamides |
| 07/23/2008 | CN101228153A Preparation of terazole derivatives |
| 07/23/2008 | CN101228152A N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/23/2008 | CN101228137A Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 07/23/2008 | CN101228135A Pyridazinone derivatives as thyroid hormone receptor agonists |
| 07/23/2008 | CN101228134A Substituted arylpyrazoles as antiparasitic agent |
| 07/23/2008 | CN100404511C 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 07/23/2008 | CN100404505C Novel substituted indoles |
| 07/22/2008 | US7402683 Cinnamic acid amides |
| 07/22/2008 | US7402676 Substituted dihydro 3-halo-1H-pyrazole-5-carboxylates their preparation and use |
| 07/22/2008 | US7402606 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
| 07/22/2008 | US7402597 e.g. [[7-Allyl-3-[2-[2-(2,4-dichlorophenyl)-5-isopropyl-4-oxazolyl]ethyl]-1,2-benzisoxazol-6-yl]oxy]acetic acid; with vehicles (lactose, D-mannitol, glucose), disintegrators (starch or carboxymethylcellulose calcium ), binders (hydroxypropylcellulose) and lubricants (magnesium stearate or talc) |
| 07/22/2008 | US7402589 such as 1-(4-Fluorophenyl)-1-{2-[(1S)-2-hydroxy-1,2-dimethyl-propylamino]-pyrimidin-4-yl}-3-o-tolyl-urea; Interleukin-1, Cycloxygenase-2, Tumor Necrosis Factor- alpha antagonist; antiinflammatory agent; rheumatoid arthritis or osteoarthritis |
| 07/22/2008 | US7402585 For example, 2-(3-{[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinazolin-4-yl]amino}-1H-pyrazol-5-yl)-N-phenylacetamide; use in the treatment of certain diseases, in particular to proliferative disease such as cancer |
| 07/22/2008 | US7402582 such as 2-(2-{[6-({3-[4-(hydroxymethyl)piperidin-1-yl]propyl}oxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-4-yl]amino}-1,3-thiazol-5-yl)-N-(3-methylphenyl)acetamide; serine/threonine Aurora kinase inhibitor; anticarcinogenic agent; |
| 07/22/2008 | US7402581 3,5-Dibromo-N-[(2S)-2-(4-fluorophenyl)-4-(3-morpholin-4-ylazetidin-1-yl)butyl]-N-methylbenzamide; neurokinin 1 and 2 (NK1,2) receptors, antagonist; improved pharmacokinetics: not inhibit liver enzyme cytochrome P450, prevent drug-drug interactions, oral bioavailability, antiinflammatory and analgesic |
| 07/22/2008 | US7402580 Polymerase inhibitors; antiischemic agents; brain disorders; cardiovascular disorders; antiinflammatory agents; antiarthritic agents; neurodegenerative agents; Alzheimer's disease; muscular disorders; antidiabetic agents; kidney disorders; viricides; anticancer agents; immunosuppressants |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/17/2008 | WO2008086462A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS |
| 07/17/2008 | WO2008086122A2 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) |
| 07/17/2008 | WO2008086014A2 Bis-aryl amide derivatives useful for the treatment of cancer |
| 07/17/2008 | WO2008084218A1 Benzazole derivatives for the treatment of inflammations |
| 07/17/2008 | WO2008084073A1 Heteroaryl-substituted serine amides |
| 07/17/2008 | WO2008084057A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition |
| 07/17/2008 | WO2008084004A1 Sulfonamide derivatives as chymase inhibitors |
| 07/17/2008 | WO2008083729A1 Radiolabelling via fluorination of aziridines |
| 07/17/2008 | WO2008056257A3 Novel triazinedione derivatives as gaba-b receptor modulators |
| 07/17/2008 | WO2008050101A3 Benzoyl amino heterocyclyl compounds useful in the treatment of a disease mediated through glk |
| 07/17/2008 | WO2008042282B1 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |